For citations:
Krasnova N.M., Efremenko S.G., Evdokimova N.E., Filippova O.I., Chertovskikh Y.V., Alekseeva E.A., Tatarinova O.V., Gotovtseva A.I., Prokopev E.S., Kravchenko A.F., Vengerovskiy A.I., Sychev D.A. Influence of the NAT2 gene polymorphic markers on the effectiveness and safety of treatment in patients with newly diagnosed pulmonary tuberculosis based on peripheral red blood cell dynamics. Antibiot Khimioter = Antibiotics and Chemotherapy. 2021;66(9-10):30-38. (In Russ.) https://doi.org/10.37489/0235-2990-2021-66-9-10-30-38
Email this article 